EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of WNT signaling in papillary thyroid cancer: Mechanisms, epigenetic regulation, therapeutic resistance, and emerging clinical strategies

Zhongqiang Li, Dongxia Lv, Lingjuan Niu, Yacun Wan, Junli Li

Pathology - Research and Practice · 2025-11 · 275 · 156231

DOI: 10.1016/j.prp.2025.156231 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pathology - Research and Practice, 2025-11. Verfasst von Zhongqiang Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Health & Medical Sciences, Zhengzhou Health College, Zhengzhou, Henan 450064, China. Hauptthemen laut MEDLINE: Epigenesis, Genetic, Wnt Signaling Pathway, Thyroid Neoplasms, Thyroid Cancer, Papillary. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 127 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

WNT signaling is a key pathway that regulates cell growth, differentiation, and tissue balance. In papillary thyroid cancer (PTC), abnormal activation of both canonical (β-catenin-dependent) and non-canonical pathways contributes to tumor progression and therapy resistance. These mechanisms include reduced response to radioactive iodine (RAI), kinase inhibitors, and immunotherapies. This review outlines how WNT dysregulation drives processes such as epithelial-mesenchymal transition (EMT), cancer stem cell (CSC) plasticity, and crosstalk with major oncogenic pathways, including mitogen-activated protein kinase (MAPK), phosphoinositide 3-kinase/protein kinase B (PI3K/AKT), and transforming growth factor-β (TGF-β). We also examine the role of the tumor microenvironment (TME), where factors like fibroblast-derived cytokines and hypoxia reinforce WNT-driven resistance. Epigenetic modifiers, exosomal WNT ligands, and noncoding RNAs emerge as additional regulators. Finally, we discuss clinical implications, highlighting the value of WNT biomarkers in trials and the potential of combining WNT inhibition with RAI sensitization, MAPK blockade, or immune checkpoint therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Epigenesis, GeneticWnt Signaling PathwayThyroid NeoplasmsThyroid Cancer, PapillaryDrug Resistance, NeoplasmHumansTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

Cancer stem cellsEMTOncogenic signaling pathwaysPapillary thyroid cancerRadioactive iodineTargeted therapyTherapeutic resistanceWNT signaling

Autor:innen und Institutionen

  • School of Health & Medical Sciences, Zhengzhou Health College, Zhengzhou, Henan 450064, China.
  • School of Health & Nursing, Zhengzhou Health College, Zhengzhou, Henan 450064, China. Electronic address: 15639718373@163.com.
  • School of Health & Nursing, Zhengzhou Health College, Zhengzhou, Henan 450064, China.

Zitieren

APA

Li, Z., Lv, D., Niu, L., Wan, Y., & Li, J. (2025). The role of WNT signaling in papillary thyroid cancer: Mechanisms, epigenetic regulation, therapeutic resistance, and emerging clinical strategies. Pathology - Research and Practice, 275, 156231. https://doi.org/10.1016/j.prp.2025.156231

Vancouver

Li Z, Lv D, Niu L, Wan Y, Li J. The role of WNT signaling in papillary thyroid cancer: Mechanisms, epigenetic regulation, therapeutic resistance, and emerging clinical strategies. Pathology - Research and Practice. 2025;275:156231. doi:10.1016/j.prp.2025.156231

BibTeX
@article{Li2025,
  author = {Li, Zhongqiang and Lv, Dongxia and Niu, Lingjuan and Wan, Yacun and Li, Junli},
  title = {The role of WNT signaling in papillary thyroid cancer: Mechanisms, epigenetic regulation, therapeutic resistance, and emerging clinical strategies},
  journal = {Pathology - Research and Practice},
  year = {2025},
  volume = {275},
  pages = {156231},
  doi = {10.1016/j.prp.2025.156231}
}
Kostenlos starten →